HS Code:
The category of Halogenated, sulfonated, nitrated, or nitrosated derivatives of products of heading 2912 (HS Code: 2913) includes chemically modified derivatives of aldehydes, whether or not with other oxygen functions. These compounds are used in various industrial applications, including pharmaceuticals, agrochemicals, and organic synthesis. This category encompasses products that have undergone processes like halogenation, sulfonation, nitration, or nitrosation, altering their chemical properties for specialized uses.
Total Trade Volume
USD 1.2 billion
Data from 2022
Source
United Nations Comtrade Database
Average Rate
6.5%
Highest Rate
12% (applied by certain developing countries)
Lowest Rate
0% (under free trade agreements like EU-Japan EPA)
Growing demand in pharmaceutical intermediates
Increased production and export from countries like China and India due to rising global demand for specialized drugs.
2021-2022
Shift towards sustainable chemical processes
Pressure on manufacturers to adopt greener production methods, influencing trade costs and market access.
2020-2022
Rising raw material costs
Higher production costs have led to price increases, impacting trade competitiveness in price-sensitive markets.
2022
The European Union updated its REACH regulations, requiring more stringent documentation and testing for halogenated derivatives, affecting exporters to the EU market.
June 2023
Increased compliance costs for non-EU exporters, potentially reducing trade volumes to the region.
China announced investments in new chemical plants to boost the production of halogenated and nitrated derivatives, aiming to meet global demand.
March 2023
Likely to reinforce China's dominance in the market, potentially lowering global prices due to economies of scale.
A bilateral agreement reduced tariffs on certain chemical derivatives, including products under HS 2913, to foster trade between the two nations.
September 2022
Expected to increase trade volumes between the US and India, benefiting Indian exporters.